The study of marketing opportunities for the use of the raw material of feverfew (Tanacetum parthenium L.) in the pharmacotherapy of musculoskeletal system diseases
DOI:
https://doi.org/10.24959/sphhcj.24.310Keywords:
Tanacetum parthenium; drug market; marketing research; musculoskeletal system; rheumatoid arthritisAbstract
Aim. To form a modern idea of the market structure and trends in the consumption of drugs for the pharmacotherapy of rheumatoid arthritis, to determine the possible potential for use of plant raw material of feverfew (Tanacetum parthenium).
Materials and methods. The study was conducted using the structural analysis, logical and graphical methods, and marketing analysis methods.
Results. It was found that in the pre-war period the market for drugs affecting the musculoskeletal system developed quite vigorously – its growth rate in the period of 2020-2021 ranged from 16 to 29 % in natural units and from 20 to 30 % in monetary terms. According to the structure of producing countries, the market was significantly import-dependent. The market for synthetic drugs was quite saturated, represented by various dosage forms – tablets, powder for suspension, injection solutions (ampoules), granules, capsules, sachets, alcohol solutions, oil solutions, suppositories, oral suspensions, transdermal patches, gels, ointments. The research was conducted taking into account the study of marketing opportunities for the use of the raw material of Tanacetum parthenium in the pharmacotherapy of diseases of the musculoskeletal system since this raw material had certain advantages compared to synthetic analogs. It should be noted that the market of herbal medicines for the treatment of the musculoskeletal system diseases or the prevention of their manifestations is very limited and is represented by a minimum number of product items and one representative of the medicinal flora – Symphytum officinale. In addition, 90 % of the market for this group of drugs belongs to foreign manufacturers. Although research of the market for biological supplements indicates a certain demand for products based on the medicinal plant raw material.
Conclusions. Based on the trends identified, we can state the positive development of the market for drugs that affect the musculoskeletal system, the prospects for the development of drugs based on the medicinal plant raw material, including Tanacetum parthenium.
References
Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. 17.10.2020. The Lancet, 396, 1204–1222. Available at: https:// www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30925-9/fulltext
Dolhopolov, O. V., Polishko, V. P., Yarova, M. L. (2019). Epidemiolohiia zakhvoriuvan kistkovo-miazovoi systemy v Ukraini za period 1993-2017 rr. Visnyk ortopedii, travmatolohii ta protezuvannia, 4, 101-108.
Agarwal, S. (2011). Core Management Principles in Rheumatoid Arthritis to Help Guide Managed Care Professionals. Journal of Managed Care Pharmacy, 17, 3–9.
Alam, J., Jantan, I., Bukhari, S. (2017). Rheumatoid arthritis: recent advances on its etiology, role of cytokines and pharmacotherapy. Biomedicine & Pharmacotherapy, 1, 615-633.
Little, C., Parsons, T. (2011). Herbal therapy for treating rheumatoid arthritis. Cochrane Database Syst Rev., 1, CD002948. doi: 10.1002/14651858.CD002948.
Majnik, J., Császár-Nagy, N., Böcskei, G., Bender, T., Nagy, G. (2022). Non-pharmacological treatment in difficult-to-treat rheumatoid arthritis. Front Med (Lausanne), 9. doi: 10.3389/fmed.2022.991677.
Ataollahi, M., Akrami, E., Kalani, M., Zarei, M. (2022). Evaluation of anticoagulant and inflammatory effects of Tanacetum parthenium (L.) in a randomized controlled clinical trial. Journal of Herbal Medicine, 36. Available at: https://www.sciencedirect.com/science/article/abs/pii/S2210803322000823?via%3Dihub
Yaralioglu-Gursoy, G., Karakus, E., Ercetin, T. (2017). The effects of Tanacetum vulgare L. on blood parameters, antioxidant status and survival rate of rats. Pharm Biol., 55 (1), 569-574. doi: 10.1080/13880209.2016.1268616.
Ozguner, M., Koyu, A Cesur, G. (2008). Biological evaluation of Turkish medicinal plants for their antioxidant potentials: Tanacetum parthenium L. and Mentha spicata L. Food Chem. Toxicol., 46 (10), 3282-3287. doi: 10.1016/j.fct.2008.07.035.
Ahmadnejad-Asl-Gavgani, M., Maham, M., Dalair-Naghadeh, B. (2022). In vitro effects of essential oils of Tanacetum balsamita and carvone on the contractility of bovine ileum smooth muscles. Vet. Res. Forum., 13, 29–37. doi:10.30466/vrf.2021.521204.3118
Coté, H., Boucher, M.-A., Pichette, A., Legault, J. (2017). Anti-inflammatory, antioxidant, antibiotic, and cytotoxic activities of Tanacetum vulgare L. essential oil and its constituents. Medicines, 4, 34. doi:10.3390/medicines4020034.
Song, C. Y., Xu, Y. G., Lu, Y. Q. (2020). Use of Tripterygium wilfordii Hook F for immune-mediated inflammatory diseases: progress and future prospects. J Zhejiang Univ Sci B., 21 (4), 280-290. doi: 10.1631/jzus.B1900607.
Zhou, Y. Y., Xia, X., Peng, W. K., Wang, Q. H., Peng, J. H., Li, Y. L. et al. (2018). The Effectiveness and Safety of Tripterygium wilfordii Hook. Extracts in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis. Front Pharmacol., 9, 356. doi: 10.3389/fphar.2018.00356.
Seigner, J., Junker-Samek, M., Plaza, A., Durso, G. (2019). A Symphytum officinale Root Extract Exerts Anti-inflammatory Properties by Affecting Two Distinct Steps of NF-κB Signaling Front. Pharmacol. Sec. Ethnopharmacology, 10. doi: 10.3389/fphar.2019.00289
Ernst, E. (2008). Frankincense: systematic review. BMJ, 337, a2813. doi: 10.1136/bmj.a2813.
Postoy, V. V., Vyshnevska, L. I. (2018). The marketing research of the Ukrainian market of drugs for the treatment of arthritis. Visnyk farmatsii, 1, 38–42.
Suchasni aspekty zberezhennia zdorovia liudyny : zb. pr. KhV Mizhnar. mizhdystsyplinarnoi nauk.-prakt. konf. (2022). / za red. prof. T. M. Hanycha. Uzhhorod : DVNZ «UzhNU».
Mischenko, O., Kyrychenko, I., Gontova, T., Kalko, K., Hordiei, K. (2022). Research on the phenolic profile, antiradical and anti-inflammatory activity of a thick hydroalcoholic feverfew (Tanacetum parthenium L.) herb extract. ScienceRise: Pharmaceutical Science, 39 (5), 91–99.
Stasevych, M. V., Zvarych, V. I. (2022). Likarski zasoby hrupy М02АХ na rynku Ukrainy: analiz asortymentu ta poshuk mozhlyvykh rynkovykh nish. The role of medical science in implementing innovative medical technologies in the EU countries and Ukraine : Scientific monograph. Riga : Baltija Publishing.
Otsinka dostupnosti osnovnykh likarskykh zasobiv dlia ambulatornoho likuvannia v Ukraini (2021). / World Health Organization. Kopenhahen : Yevropeiske rehionalne biuro VOOZ. Available at: https://apps.who.int/iris/bitstream/handle/10665/343084/WHO-EURO-2021-2770-42528-59326-ukr.pdf.
Systema “Equalizer” kompanii “Business Credit”. Available at: https://bck.com.ua/blog/equalizer/chto-takoe-sistema-jekvalajzer-i-dlja-chego-ona-nuzhna.html.
Derzhavnyi reiestr likarskykh zasobiv Ukrainy. Available at: http://www.drlz.com.ua/
Kompendium: likarski preparaty. Available at: http://compendium.com.ua
Protokol “Nadannia medychnoi dopomohy dlia likuvannia koronavirusnoi khvoroby (COVID-19)” : nakaz vid 02.04.2020 r. No. 762. Available at: https://zakon.rada.gov.ua/rada/show/v0762282-20#n5480
Aptechnyi prodazh za pidsumkamy 2021r.: farmrynok prodovzhuie zrostannia, perevyshchuiuchy ochikuvannia ekspertiv. (2022). Shchotyzhnevyk Apteka, 2 (1323). Available at: https://www.apteka.ua/article/625683
Downloads
Published
Issue
Section
License
Copyright (c) 2024 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
